WILMINGTON, DE / ACCESSWIRE / February 7, 2023 / Transparency Market Research Inc. - According to a recent market report by Transparency Market Research, the lung cancer treatment market is projected to grow from US$ 39.6 Bn in 2021 and reach more than US$ 102.0 Bn by 2031. The study also predicts that the global industry would advance at a CAGR of 9.8% during the forecast period from 2022 to 2031. Rise in adoption of immunotherapies and targeted therapies for the treatment of lung cancer drives market growth. Furthermore, high rate of mortality associated with lung cancer creates increasing demand for effective novel treatment solutions, such as lung lesion treatment. Additionally, rise in demand for personalized medicine is also bolstering market expansion.

Request to Sample PDF of this Strategic Report (Use Corporate Mail ID for Top Priority): https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85369

Lung Cancer Treatment Market: Key Findings of Report

• Surge in Incidence Rate of NSCLC: Increase in incidence of non-small cell lung cancer (NSCLC) is boosting market growth. Some of the key sub-types of NSCL cancer are large cell carcinoma, squamous cell carcinoma, and adenocarcinoma. NSCL cancer type segment accounted for the largest market share in 2021. Furthermore, increase in popularity of targeted therapy solutions for treating NSCLC has also led to the expansion of this segment in recent years. Targeted therapy has emerged as the standard treatment option for treating patients suffering from advanced and aggressive forms of NSCLC.
• Hospitals End-user Segment Dominates Market: Based on end-user, the hospitals segment emerged dominant with leading market share in 2021. This can be attributed to the availability of a considerable number of lung cancer treatment options in hospitals across the globe. Hospitals offer various types of treatment solutions and therapies for treating lung cancer, such as radiation therapies, targeted therapies, immunotherapies, chemotherapies, and surgeries. Furthermore, presence of skilled professionals and well-established infrastructure for enhanced patient care and better patient outcomes also bolsters the growth of this segment.

Lung Cancer Treatment Market: Growth Opportunities

• Increase in demand for next-generation and novel cancer treatment solutions from developing economies propels market expansion
• Rise in adoption of various complementary therapeutic solutions for treating lung cancer, including herbal supplements, supplements market growth
• Surge in adoption of telemedicine solutions during the COVID-19 pandemic for monitoring & consultation of lung cancer patients presents lucrative business opportunities for industry players

Lung Cancer Treatment Market: Key Players

Leading companies operating in the global industry include Pfizer, Bristol-Myers Squibb, Novartis AG, Takeda, GlaxoSmithKline, Amgen, AstraZeneca, Eli Lilly and Company, Merck KGaA, Astellas Pharma, Johnson & Johnson, Merck MSD, Boehringer Ingelheim, AbbVie, F. Hoffmann-La Roche, and Sanofi. Players are focused on increasing their market share through adoption of various strategies, such as M&A, new product launches, and divestitures. Furthermore, they are engaged in gaining approval for new products and medications from various authorities, such as the U.S. FDA. Additionally, pharmaceutical and biotech companies operating in this domain are focusing on increasing their spending on R&D to develop new and affordable lung cancer treatment solutions.

Lung Cancer Treatment Market: Regional Growth Assessment

North America is anticipated to hold the leading market share during the forecast period in the global industry for lung cancer treatment. This can be attributed to the presence of well-established and technologically advanced healthcare infrastructure, as well as presence of a large pool of patients suffering from lung cancer in the region. Europe is also expected to present several attractive business opportunities, owing to the increasing availability of modern and advanced therapeutic treatment solutions. However, Asia Pacific is estimated to register the highest growth in the global market during the forecast period, due to rise in incidence of lung cancer, increase in geriatric population, and surge in adoption of immunotherapies as well as targeted therapies in the region.

Buy this Premium Research Report | Immediate Delivery Available -https://www.transparencymarketresearch.com/checkout.php?rep_id=85369<ype=S

Lung Cancer Treatment Market: Segmentation

Lung Cancer Treatment Market, by Cancer Type

• NSCLC
• SCLC

Lung Cancer Treatment Market, by Treatment Type

• Surgery
• Radiation Therapy
• Targeted Therapy
• Immunotherapy
• Chemotherapy
• Others (Palliative Care)

Lung Cancer Treatment Market, by End-user

• Hospitals
• Cancer & Radiation Therapy Centers
• Others (Specialty Clinics)

Lung Cancer Treatment Market, by Region

• North America
• Europe
• Asia Pacific
• Middle East & Africa
• Latin America

Ask for References - https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=85369

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:

Pharmacy Automation Devices Market

Healthcare Information System Market

Ostomy Care and Accessories Market

Centrifugal Blood Pumps Market

Orthopedic Soft Tissue Repair Market

Drug Testing Market

Digital Twin in Healthcare Market

Medical Supply Delivery Service Market

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com

SOURCE: Transparency Market Research inc.